Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 92 (1) , 78-83
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Development and validation of LC–MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphismJournal of Chromatography B, 2016
- Therapeutic Drug Monitoring of Posaconazole: an UpdateCurrent Fungal Infection Reports, 2016
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical MycologyJournal of Antimicrobial Chemotherapy, 2013
- A simple, sensitive HPLC-PDA method for the quantification of itraconazole and hydroxy itraconazole in human serum: a reference laboratory experienceDiagnostic Microbiology and Infectious Disease, 2013
- Steady-State Pharmacokinetics of Oral Voriconazole and Its Primary Metabolite, N -Oxide Voriconazole, Pre- and Post-Autologous Peripheral Stem Cell TransplantationAntimicrobial Agents and Chemotherapy, 2013
- Steady-state pharmacokinetics and metabolism of voriconazole in patientsJournal of Antimicrobial Chemotherapy, 2013
- Development and validation of a fast HPLC/photodiode array detection method for the measurement of voriconazole in human serum samples. A reference laboratory experienceEnfermedades Infecciosas y Microbiología Clínica, 2013
- HPLC/UV or bioassay: two valid methods for posaconazole quantification in human serum samplesClinical Microbiology and Infection, 2012
- Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoringXenobiotica, 2010
- IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Drug Metabolism and Disposition, 2004